the appearance of ketoconazole , the first systemic drug with relatively little toxicity , along with the appearance of ominous new forms of mycotic diseases , sharply stimulated interest in development of antifungal agents , initially in the azole classes , but now including a variety of other classes as well .
C0022625
ketoconazole
C0026946
mycotic diseases